AUPH

Aurinia Pharmace

• TipRanks·04/03 21:22

  Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline

• Reuters·04/03 20:58

  Aurinia Pharma to buy Kezar Life Sciences for $6.955 a share plus CVR

• NASDAQ·04/03 09:10

  Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS

• Reuters·04/02 20:22

  Aurinia Pharmaceuticals CFO Michael Hearne files initial beneficial ownership statement

• Reuters·04/02 20:22

  Aurinia Pharma COO Ryan Cole files initial beneficial ownership statement

• TipRanks·03/31 11:50

  Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Neumora Therapeutics, Inc. (NMRA) and Aurinia Pharmaceuticals (AUPH)

• TipRanks·03/30 22:10

  Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Aurinia Pharmaceuticals (AUPH)

• TipRanks·03/30 19:56

  Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies

• TipRanks·03/30 16:07

  Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane

• TipRanks·03/30 15:32

  Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal

• Reuters·03/30 15:06

  BUZZ-Kezar gains on Aurinia buyout deal

• Seeking Alpha·03/30 14:06

  Aurinia Pharmaceuticals acquiring Kezar Life Sciences

• NASDAQ·03/30 13:42

  Aurinia Pharma To Acquire Kezar Life Sciences For $6.96 In Cash Per Share And CVR Deal; Stock Up

• Dow Jones·03/30 13:02

  Aurinia to Acquire Kezar Life Sciences

• TipRanks·03/30 12:27

  Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR